Dihydroartemisinin is of a State first class new medicine, norcantharidin has won secondary prize for State class invention, while gliqidone alone reaches an annual sales value of 120 million Yuan.

• 年销售额为2亿元人民币。其中科泰新为国家一类新药，利佳片获国家发明二等奖，糖适平单品种销售额1.；2亿元人民币。